The Queensland and Victorian state governments join forces with New South Wales to take part in medicinal cannabis clinical trials.
Category: Research
Godwits are flexible, when they get the chance
Black-tailed godwits are able to cope with unpredictable weather, a thorough analysis finds, following the extraordinary spring of 2013 in Belgium. That year, godwits were surprised by an exceptionally cold spring upon their return to the Netherlands. Nevertheless the godwits had a particularly productive breeding season that year, authors noted.
New bowel cancer screening ‘could save 90,000 lives over 40 years’
A new bowel cancer screening program has the potential to save the lives of 90,000 Australians over the next four decades, new research shows.
Higher protein intake in infancy, possibly through formula, linked to obesity
Excessive protein intake in the first two years of an infant’s life, possibly through baby formula, could be contributing to childhood obesity, new research finds.
Using carbon nanotubes to improve bio-oil refining
New catalyst structures based on multi-walled carbon nanotubes are set to make the refining of commodity chemicals and fuels from bio-oil more competitive.
Targeted drug can ‘diminish the suffering’ of myelofibrosis
Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a researcher who co-led PERSIST-1, the worldwide phase 3 clinical trial that tested the therapy. Specifically, pacritinib substantially reduced severe enlargement of the spleen, a typical feature of advanced myelofibrosis, in more than 20 percent of patients and alleviated debilitating side effects in more than 46 percent.
Phase 2 trial identifies genetic dysfunction that makes many types of cancer vulnerable to an immunotherapy
A team of researchers has identified a genetic malfunction that predicts the effectiveness of response to a groundbreaking immunotherapy. The results of their Phase 2 clinical trial reveal that, regardless of its tissue of origin, tumors whose cells are deficient in repairing mismatched DNA sequences–and so preventing mutations–are far more susceptible to the checkpoint inhibitor pembrolizumab than those that retain this ability.
Researchers engineer E. coli to produce new forms of popular antibiotic
In Science Advances, University at Buffalo researchers will report that they have managed to turn E. coli into tiny factories for producing new forms of the popular antibiotic erythromycin — including three that were shown in the lab to kill drug-resistant bacteria.
Freezing human eggs a growing US trend
A growing number of US women are choosing to freeze their eggs to give themselves the chance to have children in the future, but questions about the trend remain.
Hybrid ships will soon be on the market
Hybrid cars have been a success. The shipping industry is now moving in the same green direction.
PEPRR intervention successfully reduces stress of cancer caregivers
Stem cell transplant is essential in the care of many blood cancers, but leaves patients requiring in-home care for months after.